More questions than answers is bound to keeppotential new investors standing one the outside looking in. When a company winds up in this situation, investors tend to think that they are hiding something.
I know that daily nrs full of fluff are just as detrimental to shareprice of said companies and noboby is more aware than I of the delays encountered as cannabinoid businesses try to jump through the uncertainty of the regulators, who are also scared of their decisions and tend to leave themselves more ways out of a jam.
Midstream changes can be killers for value added producers if they have soon to become, noncompliant product in warehouses for reasons such as advertising, serving size, strength of product. You get the idea.
I am involved in one company that had to trash 2000 cases of a product that was approved until the lawmakers changed something such that a label was non-compliant.
They wound up trashing it as the cheapest solution to the problem but that was 48,000 bottles with a potential of $10 per bottle profit, so it adds up pretty quick because some policy and lawmaker decided to revisit their decision. A half million dollars lost revenue can kill a company.
I am amazed that shareholders here don't want to talk about the financial statement that the accountant voiced concerns over a $100k entry.
That was put in that statement as a call to action for an explanation or at minimum, a reaction or a chance to fix what could be an illegal act of outright theft.
Not dealing with it by management, in this case Glen, who should have an answer for concerned shareholders. Not answering is suggestive of nefarious action or involvement.
I believe that this is a fair post of concern for shareholders and it is material and should be answered or reported to proper authorities.
No answer could be what is restraining any price appreciation!!!
glta and dyodd